Literature DB >> 21986791

[Hospital and community-acquired β-lactamases-producing Escherichia coli and Klebsiella pneumoniae at hospitals in Hermosillo, Sonora].

Moisés Navarro-Navarro1, Ramón Enrique Robles-Zepeda, Adriana Garibay-Escobar, Eduardo Ruiz-Bustos.   

Abstract

OBJECTIVE: To determine the prevalence of extended-spectrum β-lactamases (ESBL)-producing Esherichia coli and Klebsiella pneumoniae in hospitals of Hermosillo, Sonora, Mexico.
MATERIAL AND METHODS: To detect ESBL-production, 1 412 bacterial isolates obtained over a one year period (2008-2009) were analyzed using the double-disk synergy test, with and without clavulanic acid.
RESULTS: Hospitalaryacquired ESBL-producing E.coli and K.pneumoniae (31.8% and 35.3%) were isolated with higher prevalence that community-acquired isolates (14.4% and 0.0%) (p<0.005).
CONCLUSIONS: Our study shows the presence of ESBL-producing bacteria in the three hospitals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21986791     DOI: 10.1590/s0036-36342011000400009

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  3 in total

1.  Frequency of Extended-Spectrum Beta-lactamases (ESBLs) in strains of Klebsiella and E. coli isolated from patients hospitalized in Yazd.

Authors:  Hengameh Zandi; Seyed Mostafa Tabatabaei; Fatemeh Ehsani; Mojtaba Babaei Zarch; Samira Doosthosseini
Journal:  Electron Physician       Date:  2017-02-25

2.  Association of Antibiotic Resistance, Cell Adherence, and Biofilm Production with the Endemicity of Nosocomial Klebsiella pneumoniae.

Authors:  María Dolores Alcántar-Curiel; Carmen Alejandra Ledezma-Escalante; Ma Dolores Jarillo-Quijada; Catalina Gayosso-Vázquez; Rayo Morfín-Otero; Eduardo Rodríguez-Noriega; María Lilia Cedillo-Ramírez; José Ignacio Santos-Preciado; Jorge A Girón
Journal:  Biomed Res Int       Date:  2018-09-23       Impact factor: 3.411

Review 3.  Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America.

Authors:  Manuel Guzmán-Blanco; Jaime A Labarca; Maria Virginia Villegas; Eduardo Gotuzzo
Journal:  Braz J Infect Dis       Date:  2014-01-03       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.